CNN HEALTHCARE LTD

Executive Summary

CNN Healthcare Ltd remains dormant with minimal financial activity and an insignificant asset base, providing no evidence of operational viability or creditworthiness. The company’s inability to generate cash flow or maintain working capital presents a clear risk for any credit facility. Approval for credit is not recommended unless significant positive changes in trading and financial performance are demonstrated.

CNN HEALTHCARE LTD - Analysis Report

Company Number: 13717276

Analysis Date: 2025-07-19 12:46 UTC

1. Credit Opinion: DECLINE. CNN Healthcare Ltd is classified as a dormant company with negligible financial activity and minimal assets (£2 current assets, £2 net assets) over the last three years. There is no trading history, no employees, and no income or cash flow generation reported. The company has not demonstrated operational or financial activity to support debt servicing or repayment capabilities. The absence of financial substance and trading performance presents a high credit risk.

2. Financial Strength: The balance sheet reflects an extremely low asset base with net assets and shareholders' funds of only £2 consistently over three years. The company holds no fixed assets, no working capital beyond a nominal £2 current asset, and no retained earnings or reserves. This indicates no operational scale or financial buffer to absorb shocks or sustain business activity.

3. Cash Flow Assessment: With no reported revenue, no employees, and a dormant status, there are no meaningful cash flows from operations. Current assets of £2 suggest no liquidity beyond a trivial amount, and there are no reported liabilities. The company lacks working capital capacity to meet any financial obligations or support business operations.

4. Monitoring Points:

• Monitor any changes in trading status from dormant to active with the emergence of financial statements showing revenue and expenses.
• Watch for updated filings indicating operating cash flows, profitability, or capital injections.
• Keep an eye on director changes or PSC control shifts that might signal restructuring or new business activity.
• Ensure annual accounts and confirmation statements continue to be filed timely to avoid compliance risks.